Shin Yeu Ong

14PUBLICATIONS
56CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursPredictive and prognostic markersMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 25, 2026
Outcomes of patients with relapsed or refractory classic Hodgkin lymphoma after frontline brentuximab vedotin.

|Mar 27, 2026
Impact of novel therapies on the efficacy of posttransplantation brentuximab vedotin maintenance in Hodgkin lymphoma.

Ayo Samuel Falade, Robert Redd, Sanjal H Desai

|Mar 17, 2026
Tailored approaches in mantle cell lymphoma: refining treatment paradigms with an expert panel opinion.

Won Seog Kim, Mubarak Al Mansour, Chan Cheah

|Dec 17, 2025
PD-1-based combinations before autologous transplant are associated with improved outcomes in classical Hodgkin lymphoma.

Sanjal H Desai, Alison J Moskowitz, Reid W Merryman

|Dec 28, 2024
Outcome of extra-nodal follicular lymphoma affected by choice of induction chemoimmunotherapy and maintenance rituximab - real-world retrospective study.

Lawrence Cheng Kiat Ng, Shin Yeu Ong, Xinxin Huang

|Feb 02, 2024
Aggressive T-cell lymphomas: 2024: Updates on diagnosis, risk stratification, and management.

Shin Yeu Ong, Jasmine M Zain

Pageof 3

Frequent Collaborators

3 joint publications

Matthew Mei

3 joint publications

Sanjal H Desai

3 joint publications

Alex F Herrera

2 joint publications

Nicholas Grigoropoulos